Osteo Arthritis Knee: Clinical Trials

12 trials for Osteo Arthritis Knee, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 active not recruiting, 2 unknown, 1 not yet recruiting. 12 Phase 1, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 112Completed 5, Active not recruiting 2, Unknown 2, Not yet recruiting 1, Terminated 1, Withdrawn 1
Phase 26Completed 2, Active not recruiting 1, Not yet recruiting 1, Unknown 1, Withdrawn 1

Follow Osteo Arthritis Knee: new trials by email Literature Review of Osteo Arthritis Knee trials Research Report on Osteo Arthritis Knee

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Tolerability of StroMel™ in Subjects with Moderate to Severe Osteoarthritis of the Knee Joint
StroMel - Osteo Arthritis Knee
Phase 1 / Phase 2Not yet recruitingAkan Biosciences, LLC202025-10-012025-01-29
The Role of Vitamin K on Knee Osteoarthritis Outcomes
Vitamin K1 500 µg, K1 1000 µg, Vitamin K2 (MK-7) 300 µg - Osteo Arthritis Knee
Phase 1 / Phase 2Active not recruitingBoston University492025-06-032026-09-21
A Study to Evaluate the Safety of Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte for the Treatment of Knee Osteoarthritis
Human Allogenic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte) - Osteo Arthritis Knee
Phase 1 / Phase 2CompletedCellcolabs Clinical SPV Limited122023-11-072026-04-16
Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
GNSC-001, transient immune-modulation, Placebo - Osteoarthritis, Knee, Osteo Arthritis Knee
Phase 1Active not recruitingGenascence Corporation672023-06-122025-08-01
Altering Bone Microarchitecture and Mechanics by Off-label Pharmaceutical Intervention Following an Acute Knee Injury
Zoledronic Acid Injection, Placebo - Anterior Cruciate Ligament Tear, Anterior Cruciate Ligament Rupture
Phase 1TerminatedUniversity of Calgary42023-05-162025-12-02
OA Optimization Program Pilot Trial
Alberta Healthy Living Program, Alberta Obesity Centre Program, Osteoarthritis advice - Osteo Arthritis Knee, Osteoarthritis, Knee
Phase 1 / Phase 2UnknownUniversity of Calgary702022-06-282024-05-22
Melatonin Use After Primary Total Joint Arthroplasty
Melatonin 5 mg, Placebo - Osteo Arthritis Knee
Phase 1CompletedNYU Langone Health2942021-07-122025-05-04
pAF for the Treatment of Osteoarthritis
Amniotic Fluid Injection, Standard of Care - Osteo Arthritis Knee
Phase 1 / Phase 2CompletedUniversity of Utah602021-07-082026-03-27
The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Patients With Knee Osteoarthritis
Metformin, Placebo - Osteo Arthritis Knee
Phase 1 / Phase 2WithdrawnSadat City University2021-02-162025-07-14
Sustained Acoustic Medicine (SAM) Combined With a Diclofenac Ultrasound Coupling Patch for Knee Osteoarthritis
Sustained Acoustic Device with 1% Diclofenac patch - Osteo Arthritis Knee, Arthritis
Phase 1CompletedZetrOZ, Inc.342019-09-012023-06-27
Intra-articular Transplantation of Autologous Adipose Derived Stromal Vascular Faction (SVF) for Treatment of Osteoarthritis of the Knee
Autologous Adipose-Derived SVF (Stromal Vascular Fraction), Placebo - Osteo Arthritis Knee, Degenerative Joint Disease of Knee
Phase 1CompletedMayo Clinic92019-07-022026-01-27
[Tc-99m]-RPI-087 as an Imaging Marker in Osteoarthritis of the Knee Compared to Healthy Volunteers
[Tc-99m]-RPI-T-087 Injection - Healthy, Osteo Arthritis Knee
Phase 1UnknownReiley Pharmaceuticals Inc.242018-08-162019-01-15

Narrower conditions

Osteoarthritis, Knee (3)  ·  Osteoarthritis (2)  ·  Anterior Cruciate Ligament Injuries (1)  ·  Arthritis (1)  ·  Osteoarthritis, Hip (1)

Broader conditions

Joint Diseases (4)  ·  Musculoskeletal Diseases (4)  ·  Arthritis (3)  ·  Rheumatic Diseases (3)  ·  Knee Injuries (1)  ·  Leg Injuries (1)  ·  Osteoarthritis (1)  ·  Wounds and Injuries (1)

Interventions

Educational Status (1)  ·  Exercise (1)  ·  MICU1 protein, human (1)  ·  Melatonin (1)  ·  Metformin (1)  ·  Physical Therapy Modalities (1)  ·  Platelet Activating Factor (1)  ·  Sodium Chloride (1)  ·  Standard of Care (1)  ·  Sugars (1)  ·  Vitamin K 1 (1)  ·  Vitamin K 2 (1)  ·  Zoledronic Acid (1)

Sponsors

University of Calgary (2)  ·  Akan Biosciences, LLC (1)  ·  Boston University (1)  ·  Cellcolabs Clinical SPV Limited (1)  ·  Genascence Corporation (1)  ·  Mayo Clinic (1)  ·  NYU Langone Health (1)  ·  Reiley Pharmaceuticals Inc. (1)  ·  Sadat City University (1)  ·  University of Utah (1)  ·  ZetrOZ, Inc. (1)

Countries

United States (7)  ·  Canada (3)  ·  Egypt (1)  ·  United Arab Emirates (1)

Top investigators

David Petron, MD (1)  ·  Fahti Yousef, PhD (1)  ·  Gregory Kline, MD (1)  ·  Jean Liew, MD MS (1)  ·  Jeymi Tambiah, MBChB (1)  ·  Joshua C Rozell, MD (1)  ·  Karen Gulenchyn, MD (1)  ·  Ralph Ortiz, DO (1)  ·  Shane A Shapiro (1)  ·  Steven Boyd, PhD (1)

Results publications

PMID 33408796, PMID 38401621, PMID 39284030, PMID 40826764, PMID 41607103

NIH funding

K23AR082938 (1)